人多能干细胞衍生的类器官作为肝病模型
研究用 H1 人胚胎干细胞和诱导多能干细胞,经化学限定无血清培养基三维分化为肝母细胞球,再接种形成包含肝细胞和胆管细胞的肝类器官,该体系可模拟胆汁淤积和 NASH 等复杂肝病。
要点
- 肝类器官由肝细胞和胆管细胞组成,具白蛋白及载脂蛋白 B 分泌和细胞色素 P450 活性。
- 类器官形成功能性胆毛细管网络,可被曲格列酮等胆汁淤积诱导药物破坏。
- 游离脂肪酸孵育的类器官基因表达特征与 NASH 患者肝组织相似,并出现胆毛细管网络退变和胆管反应。
核心结论
- 建立了人细胞来源的肝类器官平台,可用于模拟包括 NASH 在内的复杂肝病。
研究设计与样本
- 研究用 H1 人胚胎干细胞(WA-01,第27-40代)和诱导多能干细胞(GM23338),经系列化学限定无血清培养基诱导为后前肠细胞,再三维分化为肝内胚层球和肝母细胞球,重接种后形成肝类器官。
主要发现
- 类器官细胞依据白蛋白和细胞角蛋白7表达分化为肝细胞和胆管细胞。
- 肝细胞具功能,依据为分泌白蛋白和载脂蛋白B及细胞色素P450活性;胆管细胞具功能,依据为γ谷氨酰转移酶和碱性磷酸酶活性及对促胰液素的增殖反应。
- 类器官组织成功能性胆毛细管系统,可被曲格列酮等胆汁淤积诱导药物破坏。
- 游离脂肪酸孵育的类器官基因表达特征与NASH患者肝组织相似,并出现胆毛细管网络退变和胆管反应等与非酒精性脂肪性肝病相关的结构改变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: There are few in vitro models for studying the 3-dimensional interactions among different liver cell types during organogenesis or disease development. We aimed to generate hepatic organoids that comprise different parenchymal liver cell types and have structural features of the liver, using human pluripotent stem cells. METHODS: We cultured H1 human embryonic stem cells (WA-01, passage 27-40) and induced pluripotent stem cells (GM23338) with a series of chemically defined and serum-free media to induce formation of posterior foregut cells, which were differentiated in 3 dimensions into hepatic endoderm spheroids and stepwise into hepatoblast spheroids. Hepatoblast spheroids were reseeded in a high-throughput format and induced to form hepatic organoids; development of functional bile canaliculi was imaged live. Levels of albumin and apolipoprotein B were measured in cell culture supernatants using an enzyme-linked immunosorbent assay. Levels of gamma glutamyl transferase and alkaline phosphatase were measured in cholangiocytes. Organoids were incubated with troglitazone for varying periods and bile transport and accumulation were visualized by live-imaging microscopy. Organoids were incubated with oleic and palmitic acid, and formation of lipid droplets was visualized by staining. We compared gene expression profiles of organoids incubated with free fatty acids or without. We also compared gene expression profiles between liver tissue samples from patients with nonalcoholic steatohepatitis (NASH) versus without. We quantified hepatocyte and cholangiocyte populations in organoids using immunostaining and flow cytometry; cholangiocyte proliferation of cholangiocytes was measured. We compared the bile canaliculi network in the organoids incubated with versus without free fatty acids by live imaging. RESULTS: Cells in organoids differentiated into hepatocytes and cholangiocytes, based on the expression of albumin and cytokeratin 7. Hepatocytes were functional, based on secretion of albumin and apolipoprotein B and cytochrome P450 activity; cholangiocytes were functional, based on gamma glutamyl transferase and alkaline phosphatase activity and proliferative responses to secretin. The organoids organized a functional bile canaliculi system, which was disrupted by cholestasis-inducing drugs such as troglitazone. Organoids incubated with free fatty acids had gene expression signatures similar to those of liver tissues from patients with NASH. Incubation of organoids with free fatty acid-enriched media resulted in structural changes associated with nonalcoholic fatty liver disease, such as decay of bile canaliculi network and ductular reactions. CONCLUSIONS: We developed a hepatic organoid platform with human cells that can be used to model complex liver diseases, including NASH.
引用
- Ramli MNB, Lim YS, Koe CT, et al. Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease. Gastroenterology. 2020. PMID: 32553762. doi:10.1053/j.gastro.2020.06.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。